Skip to content

Best longevity peptides for anti-aging and cellular repair.

Reviewed by CureMed LabsUpdated
A pharmacist's hands holding a small glass vial of peptide medication and a syringe on a pharmacy counter
Almost every peptide worth taking seriously is an approved drug prescribed for a real indication — not a compounded product bought online.
Simply put

Nearly every peptide is sold as repairing cells or reversing ageing. Only one has shown a repair effect in people — GHK-Cu, on skin, in small trials. Tesamorelin genuinely reduces belly fat in patients with a specific condition. Everything else — BPC-157, TB-500, epitalon, MOTS-c and the growth-hormone peptides — has results in animals or cells, or none, and no peptide has been shown to slow ageing in a healthy person.

The short answer

Ranked on human evidence for the specific repair or anti-ageing claim each peptide carries, the list is short at the top: GHK-Cu applied to skin has small human trials showing improved skin appearance and wound healing, and ranks first because it is the only peptide with a measured repair effect in people; tesamorelin has Phase 3 evidence for reducing visceral fat and a signal on liver fat, which is a metabolic-ageing effect if not a repair one; thymosin alpha-1 has immune-modulation trials in specific diseases. Everything else sold for cellular repair — BPC-157 (tissue healing), TB-500 (tissue repair), epitalon (telomeres), MOTS-c (mitochondria), sermorelin and CJC-1295/ipamorelin (growth hormone), SS-31 (mitochondrial membranes, a real drug candidate in trials) — has animal or cell data, an early trial for a disease that is not ageing, or nothing. No peptide has been shown to repair cells or slow ageing in a healthy human. The compounds with the strongest human evidence for cellular-repair biology are not peptides.

  • 'Cellular repair' names a mechanism in a dish; the ranking asks which peptides have shown a repair outcome in a human, and one has — on skin.
  • Tesamorelin's fat-loss evidence is real, approved, and for a patient population; it is the closest any injectable comes to a measured anti-ageing effect.
  • The telomere claim for epitalon rests on decades-old reports with no independent replication; telomere length is not a validated target anyway.
  • The mitochondrial peptides — MOTS-c, SS-31 — have the best biology and, respectively, no human trial and trials for diseases that are not ageing.
  • BPC-157 and TB-500 are the most-sold repair peptides and the least-studied in humans; the gap between reputation and evidence is widest here.
Cellular repair is the most common claim on a peptide label and the least often tested. It names a mechanism — tissue regeneration, mitochondrial function, telomere maintenance, collagen synthesis — that can be demonstrated in a dish or a rodent and then attached to a product without anyone measuring whether the repair happens in a person. The way to rank the claims is to ask, for each peptide, what specifically it is supposed to repair and whether that has been shown in a human.
This guide does that, peptide by peptide, and grades consistently with the site's compound pages. It is written by a pharmacist, which is why the growth-hormone axis peptides are assessed for what raising IGF-1 does as well as for what it is claimed to repair.

Peptides ranked on their repair and anti-ageing evidence

Ranked on: whether the specific repair or anti-ageing claim has been shown in a human — a measured outcome, in a trial, in people — and how strong that evidence is. Mechanism in cells or animals earns at most a C.

Verdict at a glance
#OptionVerdictGrade
1GHK-Cu (topical)The only peptide with a measured repair effect in humansGRADE CEarly
2TesamorelinMeasured fat loss in patients; a metabolic-ageing effect, not repairGRADE AEstablished
3Thymosin alpha-1Immune modulation in disease trials; no ageing outcomeGRADE CEarly
4SS-31 (elamipretide)Real mitochondrial drug candidate; trials in disease, not ageingGRADE CEarly
5SermorelinRaises GH; 'repair' is inference from the hormoneGRADE BPromising
6EpitalonTelomere claim without replication or a validated targetGRADE DInsufficient or unsafe
7MOTS-cGenuine mitochondrial peptide; zero human trialsGRADE DInsufficient or unsafe
8BPC-157The most-sold repair peptide; no human trialGRADE DInsufficient or unsafe
9TB-500 (thymosin beta-4 fragment)Real molecule with human data by other routes; none for thisGRADE DInsufficient or unsafe
10CJC-1295 and ipamorelinRaise GH and IGF-1; no repair outcome; regulatory concernsGRADE DInsufficient or unsafe
  1. 01

    GHK-Cu (topical)

    GRADE CEarlyThe only peptide with a measured repair effect in humans

    Small human trials on skin show improved appearance, elasticity and wound healing with topical copper peptide. It is a modest, local, cosmetic-scale effect — which is still more than any injectable on this list can show. Ranked first with a C because the outcome is real and small; injectable GHK-Cu for 'systemic repair' has no human data.

  2. 02

    Tesamorelin

    GRADE AEstablishedMeasured fat loss in patients; a metabolic-ageing effect, not repair

    Phase 3 trials show reduced visceral fat in HIV-associated lipodystrophy, with a signal on liver fat in later work. That is a genuine, approved, measured effect on a marker that tracks metabolic ageing. It is not cellular repair and it was not measured in healthy adults; grade A for evidence, with the indication caveat that applies everywhere on this site.

  3. 03

    Thymosin alpha-1

    GRADE CEarlyImmune modulation in disease trials; no ageing outcome

    Has human trials as an immune modulator in hepatitis, some cancers and sepsis, with an approval in some countries. The 'immune ageing' claim extrapolates from those; no trial in healthy older adults measures an ageing outcome. Not lawfully compoundable from bulk in the US.

  4. 04

    SS-31 (elamipretide)

    GRADE CEarlyReal mitochondrial drug candidate; trials in disease, not ageing

    A mitochondrial-membrane-targeting peptide with genuine human trials in Barth syndrome and primary mitochondrial myopathy, with mixed results. The best mitochondrial biology on this list and the only one in a proper development programme — for rare diseases. Not available as an anti-ageing product; anything sold under the name online is unverified.

  5. 05

    Sermorelin

    GRADE BPromisingRaises GH; 'repair' is inference from the hormone

    Reliably stimulates growth-hormone release with a long safety record. The repair claim is that GH and IGF-1 promote tissue maintenance; the counter-evidence is that lower IGF-1 associates with longer life in several species and some human cohorts. Grade B for a known pharmacology; the repair outcome has not been measured.

  6. 06

    Epitalon

    GRADE DInsufficient or unsafeTelomere claim without replication or a validated target

    Decades-old Russian reports of telomerase activation and lifespan effects, never independently replicated. Telomere length is itself not a validated individual biomarker. The claim is specific and unsupported.

  7. 07

    MOTS-c

    GRADE DInsufficient or unsafeGenuine mitochondrial peptide; zero human trials

    A mitochondrial-derived peptide with interesting rodent data on metabolism and exercise capacity. No human trial exists. Sold as an injectable with the grey-market sourcing risks.

  8. 08

    BPC-157

    GRADE DInsufficient or unsafeThe most-sold repair peptide; no human trial

    Tendon, ligament, gut and vascular healing in rodents across three decades of studies from largely one research group; no completed human trial of any repair outcome. The gap between reputation and evidence is widest here.

  9. 09

    TB-500 (thymosin beta-4 fragment)

    GRADE DInsufficient or unsafeReal molecule with human data by other routes; none for this

    Thymosin beta-4 has been studied in humans for eye and cardiac indications; the fragment sold as TB-500, injected for musculoskeletal repair, has not. Cell and animal data only for the claim it is sold on.

  10. 10

    CJC-1295 and ipamorelin

    GRADE DInsufficient or unsafeRaise GH and IGF-1; no repair outcome; regulatory concerns

    The 'repair' story is the growth-hormone story again, with the added regulatory citations of vasodilatory reactions and serious adverse events. Where tested against placebo on outcomes that matter, no benefit.

The claim, and what has actually been shown

Repair claims against the human evidence

PeptideClaimed to repairShown in humansShown only in animals or cells
GHK-Cu (topical)Skin, collagen, woundsSkin appearance, wound healing — small trialsBroad gene-expression effects
TesamorelinMetabolic ageing (via fat)Visceral fat reduction in a patient population
Thymosin alpha-1Immune functionImmune modulation in specific diseases'Immune ageing'
SS-31Mitochondrial membranesMixed results in rare mitochondrial diseasesAgeing muscle and heart in rodents
Sermorelin / CJC-1295 / ipamorelinTissue via GH/IGF-1GH and IGF-1 riseAny repair outcome
EpitalonTelomeresNothing replicatedTelomerase activation, rodent lifespan
MOTS-cMitochondria, metabolismNothingExercise capacity, insulin sensitivity in mice
BPC-157Tendon, ligament, gut, vesselsNothingExtensive rodent healing data
TB-500Muscle, tendon, heartNothing by this routeCell migration, rodent repair
The third column is the ranking. The fourth is the marketing.

Frequently asked questions

Which peptide is best for anti-ageing and cellular repair?

On human evidence for a repair outcome, topical GHK-Cu: small trials show improved skin appearance and wound healing. Tesamorelin has approved Phase 3 evidence for reducing visceral fat in a patient population — a metabolic-ageing effect rather than repair. Every injectable sold for cellular repair — BPC-157, TB-500, epitalon, MOTS-c, the growth-hormone peptides — has animal or cell data only. No peptide has been shown to repair cells or slow ageing in a healthy human.

Does BPC-157 repair tissue in humans?

It has not been shown to. Three decades of rodent studies, largely from one research group, show healing of tendon, ligament, gut and vessels in animals; no completed human trial exists for any repair outcome. It is the most-sold repair peptide and the least-studied in people.

Does epitalon lengthen telomeres?

The claim rests on decades-old Russian reports of telomerase activation and lifespan effects that have never been independently replicated. Telomere length is also not a validated biomarker for an individual — it has no target, a large noise band and no planned response — so even a confirmed effect would be hard to interpret.

Are growth-hormone peptides good for cellular repair?

They raise growth hormone and IGF-1 reliably; that is where the repair claim comes from. The same axis, when lower, associates with longer life across species and in some human cohorts, and when higher, with certain cancers. No repair outcome has been measured in healthy adults. Tesamorelin, the approved one, was tested in a condition where the trade-off was measured; the rest were not.

What about SS-31 or MOTS-c for mitochondria?

SS-31 (elamipretide) is a genuine drug candidate with human trials in rare mitochondrial diseases and mixed results; it is not available as an anti-ageing product, and anything sold under that name online is unverified. MOTS-c has interesting rodent data and no human trial at all. The mitochondrial biology is real; the human ageing evidence is not there.

Is topical GHK-Cu worth using?

For skin, it is the one peptide with a measured human effect — modest improvements in appearance and wound healing in small trials — and a genuine safety record in cosmetics. It is a skincare ingredient with evidence, not a longevity intervention, and the site's skincare guide ranks it alongside retinoids and sunscreen, which have far larger trials.

Keep reading

More in Peptides

  • Peptides and therapies commonly used to extend lifespan.

    Peptides and adjacent therapies marketed for lifespan extension ranked on human evidence: GLP-1 agonist peptides with outcome trials, growth-hormone-releasing peptides, BPC-157 and other repair peptides, NAD+ infusion therapy, and 'longevity peptide stacks' — with what is actually proven versus what is commonly used.

  • Which longevity peptides are best for energy and recovery?

    BPC-157, TB-500, MOTS-c, CJC-1295, ipamorelin, sermorelin, tesamorelin — ranked on human trials for energy and recovery. Most have none. Here is what actually exists.

  • What are the safest and best longevity peptides?

    Longevity peptides ranked on safety and human evidence together: tesamorelin, PT-141, sermorelin, GHK-Cu, semax and selank, DSIP, then the unregulated injectables — BPC-157, TB-500, MOTS-c, CJC-1295/ipamorelin, epitalon, AOD-9604, melanotan II — with the regulatory status of each.

  • Which longevity peptides work best for lifespan extension?

    Which longevity peptides have any evidence for extending lifespan, ranked honestly: none in humans; the animal data behind epitalon, MOTS-c, SS-31, humanin and the GH-axis peptides; and why the best-evidenced lifespan interventions are not peptides.

  • Best longevity peptides for beginners to start with.

    Longevity peptides for beginners, ranked on what a first peptide should be — lawful, prescribed, human-studied, low-risk: topical GHK-Cu, then approved peptides via a prescriber, then the grey-market injectables that beginners are usually sold first and should try last, if at all.

  • What are the top doctor-recommended longevity peptides?

    Doctor-recommended longevity peptides ranked by what the recommendation rests on: guideline-backed prescribing (tesamorelin, bremelanotide), evidence-informed off-label use (sermorelin), and the clinic-menu peptides — BPC-157, TB-500, CJC-1295/ipamorelin — that are recommended commercially and cannot be lawfully compounded.

Reader reviews

No reviews yet — be the first.
Write a review

Every review is read by our team before it publishes. We remove nothing for being negative — only for being fake, off-topic or abusive.

The Longevity Brief

One evidence-graded email a week: what is new in longevity research, what is hype, and the one change actually worth making.

Free · one email a week · unsubscribe anytime.